CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$278.06
−1.28%Forward multiples
Based on analyst estimates
- P/E forward
- 22.58x
- P/E 2026E
- 24.51x
- P/E 2027E
- 21.79x
- P/E 2028E
- 19.57x
- P/S forward
- 3.41x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.67x
- Price / sales
- 3.32x
- Price / cash flow
- 22.80x
Enterprise value
- Enterprise value
- $16.1B
- EV / sales
- 4.03x
- EV / EBITDA
- 73.10x
- EV / EBIT
- 32.64x
- Market cap
- $13.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026